Adempas (Riociguat) for Pulmonary Hypertension

Author: Shelley Ensz. Scleroderma is highly variable. See Types of Scleroderma. Read Disclaimer

Adempas (Riociguat) by Bayer Schering

Take the Next Step With Adempas. Adempas is the first and only medicine approved by the Food and Drug Administration (FDA) for treating two types of pulmonary hypertension in adults: Chronic thromboembolic pulmonary hypertension (CTEPH) and Pulmonary arterial hypertension (PAH). Bayer HealthCare Pharmaceuticals.

Riociguat Drug Information. Prescribing information, side effects, and contraindications. Drugs.com.

Go to Stem Cell Transplants

SCLERO.ORG is the world's leading nonprofit for trustworthy research, support, education and awareness for scleroderma and related illnesses. We are a 501(c)(3) U.S.-based public charitable foundation, established in 2002. Meet Our Team. Donations may also be mailed to:

International Scleroderma Network (ISN)
7455 France Ave So #266
Edina, MN 55435-4702 USA

Email [email protected]. Disclaimer. Privacy Policy.